Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.700
-0.040 (-0.84%)
At close: Jul 31, 2026, 4:00 PM EDT
4.705
+0.005 (0.11%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Atea Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Atea Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $8.67. The average 1-year stock price forecast is 84.47% higher than the current stock price, while the lowest is $6.00 (+27.66%) and the highest is $10 (+112.77%).
Price Target: $8.67 (+84.47%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Atea Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $6 | Hold | Maintains | $6 | +27.66% | Jul 29, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 28, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $6 → $10 | Buy | Maintains | $6 → $10 | +112.77% | Mar 9, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
30.17M
EPS This Year
-1.93
from -1.94
EPS Next Year
-1.39
from -1.93
EPS and Forward PE are based on non-GAAP adjusted numbers.